INSP Stock Analysis: Buy, Sell, or Hold?
INSP - Inspire Medical Systems, Inc.
$51.76
0.24 (0.47%)
▲
5d:
+10.24%
30d:
+22.62%
90d:
-8.7%
HOLD
MODERATE Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 03, 2026
20d
Get Alerted When INSP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: INSP is 9.1% above its trading range ($47.43). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: INSP is 9.1% above its trading range ($47.43). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$62.38
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$38.74
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INSP is currently trading at $51.76, which is considered extended relative to its 30-day fair value range of $40.61 to $47.43. From a valuation perspective, the stock is trading at a premium (Forward PE: 40.4) compared to its historical average (36.3). At these levels, the market is pricing in 3.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, INSP is in a strong downtrend. The price is approaching resistance at $51.86. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: INSP has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, INSP is in a strong downtrend. The price is approaching resistance at $51.86. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: INSP has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$40.61 -
$47.43
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
53.3%
Protect Your Profits
INSP is technically overbought (RSI 71). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+9.1% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($51.77)
- NEUTRAL: Market pricing in 3.6% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$40.61 -
$47.43
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$42.81
Resistance Level
$51.86
Current Trend
Strong Downtrend
Technical data as of
Jul 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
40.39
Wall Street Target
$51.77
Revenue Growth (YoY)
1.6%
Earnings Growth (YoY)
308.4%
Profit Margin
14.3%
Valuation Premium vs History
+3.6% premium
PE vs Historical
40.4 vs 36.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.6%
(market-implied from PE analysis)
1-Year Target
$53.62
(+4%)
2-Year Target
$55.55
(+7%)
3-Year Target
$57.55
(+11%)
3-Yr Target (if PE normalizes)
(PE: 40→36)
PE COMPRESSION
$51.72
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 40.4, Growth: 41.4%)
$146.39
(+183%)
Base:
(SPY PE: 21.8, Growth: 41.4%)
$78.93
(+53%)
Bear:
(PE: 18.5, Growth: 41.4%)
$67.09
(+30%)
📈
Valuation based on Current Earnings
Trailing PE: 11.20 | Current EPS (TTM): $4.60
Bull Case
$28.34
(-45%)
Analyst growth -50.0%, PE expands to 12.3
Base Case
$25.76
(-50%)
Market implied -50.0%, PE stable at 11.2
Bear Case
$35.03
(-32%)
Severe decline -20.0%, PE contracts to 9.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 13, 2026 7:41 AM ET
Data refreshes hourly during market hours. Next update: 8:41 AM
Data refreshes hourly during market hours. Next update: 8:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INSP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 66 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 58 HOLD |
Advanced INSP Option Strategies
Professional options setups generated by AI based on today's INSP price and gamma walls.
